TOKYO -- Chugai Pharmaceutical has high hopes for obesity treatments it is working on with global partners Eli Lilly and Roche, as Japan's most profitable drugmaker focuses on its core strengths.
Global Management Dialogue 2024
Oral obesity treatment trials on track, head of Japan's Chugai says
Pharma company also pursuing anti-obesity drug with fewer side effects
Japan's Chugai Pharmaceutical is working on two potential obesity treatments together with Eli Lilly and Roche. (Photos by Takaki Kashiwabara and Manami Yamada)
Read Next
Latest on Global Management Dialogue 2024
